EDITORIAL
Published on 15 May 2024
Editorial: Immunologic tumor microenvironment modulators for turning “cold” tumors to “hot” tumors
doi 10.3389/fimmu.2024.1425136
- 634 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunologic Tumor Microenvironment Modulators for Turning "Cold" Tumors to "Hot" Tumors
Immunologic Tumor Microenvironment Modulators for Turning "Cold" Tumors to "Hot" Tumors
14k
Total Downloads
47k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 04 Apr 2024
Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
doi 10.3389/fimmu.2024.1379622
- 2,341 views
- 5 citations
REVIEW
Published on 13 Mar 2024
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
doi 10.3389/fimmu.2024.1344272
- 5,837 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 Mar 2024
Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction
doi 10.3389/fonc.2024.1364577
- 1,205 views
CLINICAL TRIAL
Published on 29 Feb 2024
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers
doi 10.3389/fimmu.2024.1362775
- 2,834 views
ORIGINAL RESEARCH
Published on 15 Feb 2024
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
doi 10.3389/fonc.2024.1357801
- 1,528 views
- 3 citations
REVIEW
Published on 24 Jan 2024
Bioactive peptides: an alternative therapeutic approach for cancer management
doi 10.3389/fimmu.2024.1310443
- 3,994 views
- 5 citations
REVIEW
Published on 16 Jan 2024
Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia
doi 10.3389/fimmu.2023.1315453
- 1,834 views
- 1 citation
ORIGINAL RESEARCH
Published on 20 Dec 2023
SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy
doi 10.3389/fimmu.2023.1326927
- 3,211 views
- 3 citations
CASE REPORT
Published on 20 Dec 2023
Making “cold” tumors “hot”- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report
doi 10.3389/fimmu.2023.1277810
- 1,434 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Nov 2023
Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma
doi 10.3389/fimmu.2023.1309138
- 1,413 views
- 2 citations
REVIEW
Published on 18 Oct 2023
It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
doi 10.3389/fimmu.2023.1241208
- 1,342 views
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 47kTopic views
- 32kArticle views
- 14kArticle downloads